{
    "version": "2025-01-09-base",
    "documents": [
        {
            "sentences": [
                {
                    "generated_prob": 0.00020178941485937685,
                    "sentence": "From the archives As part of our Platinum 70 Year, we take a look back at opinions and reports from The Australian Financial Review on significant domestic and international events over the past seven decades.The word \"unprecedented\" is regularly used to describe the COVID-19 pandemic, with some justification.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.00027773258625529706,
                    "sentence": "But not everything has been a first.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.00026453903410583735,
                    "sentence": "As this front page lead story from The Australian Financial Review of February 12, 1969, reveals, this includes the role the then government-owned CSL played in developing a world-first \"split vaccine\" to immunise people against a deadly virus.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.00021209381520748138,
                    "sentence": "The Hong Kong flu epidemic of 1968-69 caused up to an estimated 4 million deaths globally, and led to a spike in influenza mortality in Australia, but did not kill those infected on the same scale as the 1918-19 Spanish flu.INDUSTRY AWAITS GOVT.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.0001353029947495088,
                    "sentence": "ONHONG KONG FLU VACCINEThe Minister for Health, Dr [Jim] Forbes, is expected to announce this week proposed Commonwealth action to combat the expected major epidemic of the virulent Hong Kong influenza virus due to hit Australia this winter.Dr Forbes is currently studying a report of the epidemiology committee of the National Health and Medical Research Council which met in Melbourne last week.The committee was asked to make a recommendation on the efficacy and the use of the A/2 Hong Kong influenza vaccine which was developed last year by the Commonwealth Serum Laboratories.The committee is understood to have stated plainly that Australia can expect a major attack of the virus this winter.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.00013445381773635745,
                    "sentence": "The main people to be severely affected are likely to be children under five, people over 65, pregnant women, and people who suffer from chest complaints.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.04151289910078049,
                    "sentence": "Its major recommendation is understood to have been free immunisation for all children under five, pregnant women, and people over 65.It is understood that the Pharmaceutical Benefits Advisory Committee has been consulted on the problems involved in such a free immunisation plan.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.03418859466910362,
                    "sentence": "The epidemiology committee also recommended that the rest of the community be given the opportunity to obtain immunisation from the virus.The [CSL] is anxious to know the government's policy and attitude on the expected epidemic as it will take some months to move into full production of the vaccine.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.037798166275024414,
                    "sentence": "Currently the CSL is busily stockpiling the vaccine, but in the last few months of last year it had to meet an order of 1.2 million doses for the United Kingdom.Industry is also beginning to express great interest in obtaining large amounts of vaccine for staff immunisation and inquiries have been received from at least 50 Australian companies.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.3715307116508484,
                    "sentence": "In the past, industry has to a large extent taken a gamble on the likely effects of the epidemic, but this year's influx of influenza is expected to be much stronger and widespread than the last major attack in 1957.The big problem of the influenza virus is that is has the peculiar habit of changing its type every 10 years or so and immunisation against one strain has little or no effect against another.The new strain was first discovered in Hong Kong last year and the CSL also found some cases in the Northern Territory.In conjunction with the Australian National University in Canberra, the CSL worked at producing the virus in the laboratory and a vaccine from it.The vaccine produced, known as a \"split vaccine\", was the first of its type in the world and rendered the Hong Kong flu virusnon-toxic with no reaction to the patient.The vaccine is expected to be available to the Australian public some time in February or early March and will probably be obtained in three main ways:\" From chemists by a doctor's prescription.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.5037736892700195,
                    "sentence": "The practice until this year has been that such a vaccine obtained from the chemist has not been considered for registration as a pharmaceutical benefit.\"",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.48179516196250916,
                    "sentence": "A series of two injections from a doctor at a four-week interval.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.5212709307670593,
                    "sentence": "This method has the advantage of the fee being charged to the medical benefits.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.4577861726284027,
                    "sentence": "The doctor and drug companies will probably obtain the vaccine from the CSL at about 85¢ a dose.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.4878116548061371,
                    "sentence": "To this the doctor will add his normal service fee.\"",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.6818550825119019,
                    "sentence": "From an employer who has decided to have his staff vaccinated if they request it.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.5649155378341675,
                    "sentence": "Already some of the major universities... are preparing for mass immunisation programs.The extent to which the epidemic could affect Australia can be gauged from its effect on the United States.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.010241707786917686,
                    "sentence": "In 39 of the states the virus was considered to have reached epidemic proportions.The two main results of the US and UK epidemics was the effect on essential services caused by the influenza and the rise in mortality.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                },
                {
                    "generated_prob": 0.008570452220737934,
                    "sentence": "The influenza caused complications in many chest complaints that resulted in death.",
                    "perplexity": 0,
                    "highlight_sentence_for_ai": false
                }
            ],
            "paragraphs": [
                {
                    "start_sentence_index": 0,
                    "num_sentences": 19,
                    "completely_generated_prob": 7.952272508076387e-17
                }
            ],
            "completely_generated_prob": 0.07288466908684726,
            "class_probabilities": {
                "human": 0.9271153309131527,
                "ai": 0.07288466908684726,
                "mixed": 0
            },
            "average_generated_prob": 0,
            "predicted_class": "human",
            "confidence_score": 0.9271153309131527,
            "confidence_category": "high",
            "confidence_scores_raw": {
                "identity": {
                    "ai": 0.07288466908684726,
                    "human": 0.9271153309131527,
                    "mixed": 0
                }
            },
            "confidence_thresholds_raw": {
                "identity": {
                    "ai": {
                        "reject": 0.65,
                        "low": 0.75,
                        "medium": 0.92
                    },
                    "human": {
                        "reject": 0.7,
                        "low": 0.82,
                        "medium": 0.92
                    },
                    "mixed": {
                        "reject": 0.7,
                        "low": 0.8,
                        "medium": 0.88
                    }
                }
            },
            "overall_burstiness": 0,
            "writing_stats": {},
            "subclass": {
                "ai": {},
                "human": {},
                "mixed": {}
            },
            "result_message": "Our detector is highly confident that the text is written entirely by a human.",
            "document_classification": "HUMAN_ONLY",
            "version": "2025-01-09-base",
            "language": "en",
            "inputText": "From the archives As part of our Platinum 70 Year, we take a look back at opinions and reports from The Australian Financial Review on significant domestic and international events over the past seven decades.The word \"unprecedented\" is regularly used to describe the COVID-19 pandemic, with some justification. But not everything has been a first. As this front page lead story from The Australian Financial Review of February 12, 1969, reveals, this includes the role the then government-owned CSL played in developing a world-first \"split vaccine\" to immunise people against a deadly virus. The Hong Kong flu epidemic of 1968-69 caused up to an estimated 4 million deaths globally, and led to a spike in influenza mortality in Australia, but did not kill those infected on the same scale as the 1918-19 Spanish flu.INDUSTRY AWAITS GOVT. ONHONG KONG FLU VACCINEThe Minister for Health, Dr [Jim] Forbes, is expected to announce this week proposed Commonwealth action to combat the expected major epidemic of the virulent Hong Kong influenza virus due to hit Australia this winter.Dr Forbes is currently studying a report of the epidemiology committee of the National Health and Medical Research Council which met in Melbourne last week.The committee was asked to make a recommendation on the efficacy and the use of the A/2 Hong Kong influenza vaccine which was developed last year by the Commonwealth Serum Laboratories.The committee is understood to have stated plainly that Australia can expect a major attack of the virus this winter. The main people to be severely affected are likely to be children under five, people over 65, pregnant women, and people who suffer from chest complaints. Its major recommendation is understood to have been free immunisation for all children under five, pregnant women, and people over 65.It is understood that the Pharmaceutical Benefits Advisory Committee has been consulted on the problems involved in such a free immunisation plan. The epidemiology committee also recommended that the rest of the community be given the opportunity to obtain immunisation from the virus.The [CSL] is anxious to know the government's policy and attitude on the expected epidemic as it will take some months to move into full production of the vaccine. Currently the CSL is busily stockpiling the vaccine, but in the last few months of last year it had to meet an order of 1.2 million doses for the United Kingdom.Industry is also beginning to express great interest in obtaining large amounts of vaccine for staff immunisation and inquiries have been received from at least 50 Australian companies. In the past, industry has to a large extent taken a gamble on the likely effects of the epidemic, but this year's influx of influenza is expected to be much stronger and widespread than the last major attack in 1957.The big problem of the influenza virus is that is has the peculiar habit of changing its type every 10 years or so and immunisation against one strain has little or no effect against another.The new strain was first discovered in Hong Kong last year and the CSL also found some cases in the Northern Territory.In conjunction with the Australian National University in Canberra, the CSL worked at producing the virus in the laboratory and a vaccine from it.The vaccine produced, known as a \"split vaccine\", was the first of its type in the world and rendered the Hong Kong flu virusnon-toxic with no reaction to the patient.The vaccine is expected to be available to the Australian public some time in February or early March and will probably be obtained in three main ways:\" From chemists by a doctor's prescription. The practice until this year has been that such a vaccine obtained from the chemist has not been considered for registration as a pharmaceutical benefit.\" A series of two injections from a doctor at a four-week interval. This method has the advantage of the fee being charged to the medical benefits. The doctor and drug companies will probably obtain the vaccine from the CSL at about 85¢ a dose. To this the doctor will add his normal service fee.\" From an employer who has decided to have his staff vaccinated if they request it. Already some of the major universities ... are preparing for mass immunisation programs.The extent to which the epidemic could affect Australia can be gauged from its effect on the United States. In 39 of the states the virus was considered to have reached epidemic proportions.The two main results of the US and UK epidemics was the effect on essential services caused by the influenza and the rise in mortality. The influenza caused complications in many chest complaints that resulted in death."
        }
    ]
}